aminocaproic acid has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, HG | 1 |
| Cha, BG | 1 |
| Kang, DW | 1 |
| Kim, DY | 1 |
| Yang, W | 1 |
| Ki, SK | 1 |
| Kim, SI | 1 |
| Han, J | 1 |
| Kim, CK | 1 |
| Kim, J | 1 |
| Lee, SH | 1 |
| Greilich, PE | 1 |
| Okada, K | 1 |
| Latham, P | 1 |
| Kumar, RR | 1 |
| Jessen, ME | 1 |
1 trial available for aminocaproic acid and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Coronary Artery Bypass; Double-Blind Method; | 2001 |
1 other study available for aminocaproic acid and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Ceria Nanoparticles Fabricated with 6-Aminohexanoic Acid that Overcome Systemic Inflammatory Response Syndrome.
Topics: Aminocaproic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Blotting, Western; Cerium; Disea | 2019 |